With a commitment to innovation, AFT Pharmaceuticals develops, licenses and sells a wide range of products to help improve the health and wellbeing of people.
About AFT Pharmaceuticals.
Read More
Pharmaceuticals
with a difference
Browse latest news
We develop, license, and sell pharmaceutical products in Australasia and around the world. Check out our latest news.
Read More
Our range of innovative products
Learn more about our range of products.
Read More
Kiwis Thinking About Health
Kiwis Thinking About Health is an initiative from AFT Pharmaceuticals that’s designed to help New Zealanders live a healthier life.
Read More
Aussies Thinking About Health
Aussies Thinking About Health is an initiative from AFT Pharmaceuticals that’s designed to help Australians live a healthier life.
Read More
Our range of innovative products
Learn more about our range of products
Browse our products
Please select your region below to view products
Our Initiatives
Kiwis Thinking About Health
Kiwis Thinking About Health is an initiative from AFT Pharmaceuticals that’s designed to help New Zealanders live a healthier life.
Our Initiatives
Aussies Thinking About Health
Aussies Thinking About Health is an initiative from AFT Pharmaceuticals that’s designed to help Australians live a healthier life.
New clinical study shows Novaliq NovaTears® +Omega-3 eye drops is significantly effective treatment for dry eye disease.
NovaTears®+Omega-3, an innovative dry eye treatment in-licensed and distributed in Australia and New Zealand by AFT Pharmaceuticals, is a significantly effective treatment for evaporative Dry Eye Disease (DED), a new clinical study1 has found.
Read More
Maxigesic® Oral Liquid gets first regulatory approval
Maxigesic Oral Liquid – a non-opioid analgesic developed for children – achieves first approval in Europe to set up the first global launch and a pathway for further registrations and launches.
Read More
AFT at APP 2021
AFT Pharmaceuticals participate in the Australian Pharmacy Professional (APP) Conference and Trade Exhibition in May 2021.
Read More